ArticleCureus2024
Henoch-Schönlein Purpura: A Case Report and Review of Literature.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Henoch-Schönlein purpura (HSP), or anaphylactoid purpura, is an acute, self-limited small-vessel vasculitis commonly affecting children aged 3-10. It features a classic tetrad: palpable non-thrombocytopenic purpura, abdominal pain, polyarthralgia, and renal involvement. While the prognosis is generally favorable, long-term outcomes depend on renal involvement. This report describes a two-year-old boy with a two-week history of erythematous purpura, initially on the lower extremities and spreading to other areas, accompanied by painful, pruritic rash, arthralgia, and edema. A clinical diagnosis of HSP was made, and the patient was treated with topical dexpanthenol and oral paracetamol. This case highlights the importance of recognizing HSP, understanding its manifestations, and guiding treatment and long-term management. Further research is needed to clarify aspects of its pathogenesis, treatment, and prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.